Shaping the future: how cultural transformation fuels digital innovation in UK pharma

18 October 2024

An Expert View from Nick Petschek (pictured, above), Managing Director EMEA, Kotter International.

Victor Hugo once said: “nothing is more powerful than an idea whose time has come.” 

A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of industries and workflows, with no sign of stopping and providing leaders with incredible opportunities to embrace this exciting development.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical